Nanoform small is powerful logo Nanoform small is powerful logo
  • Contact Us
  • About Nanoform
    About Nanoform
    • Vision, mission and values
    • Organization
      Board of Directors
      CEO and Management Team
    • Success stories
    • Corporate Responsibility
  • Technology
    Technology
    • CESS®
      STARMAP®
    • Biologics
      Formulations
    • Case studies
  • Services
    Services
    • GMP Manufacturing
  • Corporate Governance
    Corporate Governance
    • Corporate Governance Statements
      General meeting
      Annual General Meeting 2022
      General meetings
    • The Board of Directors
      Board of Directors
      Duties of the Board of Directors
      Authorisations
      Board committees
      Remuneration of the Board
    • CEO and Management Team
      Remuneration
      Audit
      Internal Control and Risk Management
      Code of conduct
    • Articles of Association
      Insider administration
      Disclosure policy
      Transcations of managers
  • Investors
    Investors Investerare Sijoittajat
    • Financial Reports and Presentations
      Press releases
      Subscribe
    • Share and shareholders
      Share information
      Share capital development
      Certified Adviser
      Analyst Coverage
      Ownership structure
      Notifications of major shareholdings
      Manager Transactions
    • IPO 2020
    • Investor calendar
      Contact
    • Finansiella rapporter och presentationer
      Pressmeddelanden
      Prenumerera
    • Aktien och aktieägare
      Aktieinformation
      Aktiekapitalets utveckling
      Certified Adviser
      Analytiker
      Ägarstruktur
      Anmälan om betydande aktieägare
      Transaktioner utförda av personer i ledande ställning
    • Börsnotering
    • Investerarkalender
      Kontakt
    • Taloudelliset raportit ja esitykset
      Tiedotteet
      Tilaaminen
    • Osake ja osakkeeomistajat
      Tiedot osakkeesta
      Osakepääoman kehitys
      Hyväksytty neuvonantaja
      Analyytikot
      Omistusrakenne
      Ilmoitukset merkittävistä osakkeenomistajista
      Johtohenkilöiden liiketoimet
    • Listautuminen
    • Sijoittajakalenteri
      Yhteystiedot
  • Media
    Media
    • Press releases
      News
    • Pharmaceutical events
      Articles & videos
    • Subscribe
      Brochure
    • Contact
  • Careers
  • Contact

Articles & videos

2021
  • 2022
  • 2021
  • 2020
  • 2019
  • All years
All categories
  • Media
  • Videos
December 17, 2021

11th Annual PODD Recap 2021 Newsletter – Q&A with Edward Hæggström

Our CEO, Prof. Edward Hæggström was featured in the PODD 2021 newsletter where he discussed the exciting developments at Nanoform and the market trends driving the innovation. Edward also delved into the collaborations and partnerships adding value to Nanoform’s nanoparticle engineering technologies.

Learn more
November 26, 2021

Pharma Integrates 2021

Video 1: “Are you in or out?” panel discussion at Pharma Integrates 2021

Our VP of Business Development, Nathalie Huther, PhD, MRSC, shared her insights into how the pandemic has affected pharma outsourcing and what it means for the future at Pharma Integrates 2021.

Video 2: ’Forecasting Pharma’s Future” panel discussion at Pharma Integrates 2021

Our Commercial Insight Officer, Jamie Unwin, shared his perspective on the future of Pharma and patient-centric technological innovation at Pharma Integrates 2021.

Video 1 Video 2
November 26, 2021

Partnerships in Drug Delivery (PODD) 2021

Video 1: Nanotechnology Fireside Chat at Partnerships in Drug Delivery (PODD) 2021

Our CEO, Prof. Edward Hæggström, was delighted to join a fireside chat at PODD with Shawn Davies, Head of Drug Delivery, Biopharmaceuticals Development, AstraZeneca – a long term partner of Nanoform – to discuss the potential of nanoscale medicines and delivery devices to benefit patients.

Video 2: “Small is transformative: nanoparticle solutions for drug delivery innovation” at Partnerships in Drug Delivery (PODD) 2021

Our VP of US Business Development, Eric Peter, delved into the human trial results for the world’s first nanoformed drug at PODD 2021. He also discussed the ongoing industry collaborations investigating how nanoparticle engineering can facilitate drug delivery innovation to ultimately benefit patients.

Video 1 Video 2
November 17, 2021

Video: BIO-Europe 2021 fireside chat

Our Commercial Insights Officer, Jamie Unwin, sat down with Tim Pang, Executive Director, Pharma Consulting at Informa Pharma Custom Intelligence, at BIO-Europe 2021 for a fireside chat “(b)(2) or not to be – understanding the commercial returns possible from patient-centric differentiation strategies through the 505(b)(2) pathway.”
Learn more
November 16, 2021

Webinar: Tailored API Nanoparticles: How Powerful Can Small Be?

Our VP of US Business Development, Chris Worrall, hosted a webinar “Tailored API Nanoparticles: How Powerful Can Small Be?” in partnership with the American Association of Pharmaceutical Scientists (AAPS). Tune in to discover the benefits of tailoring nanoparticles for the development of patient-centric medicines.

Learn more
November 11, 2021

Nanoparticle Engineering for Patient-Centric Drug Formulation

In the final edition of PMPS in 2021, Barry Derham, Senior Formulation Scientist, delved into how nanotechnology is a way that drug manufacturers are advancing their formulations to suit ever-changing patient needs.
Learn more
November 11, 2021

Nanoparticle Engineering And 3DP Delivery For Game-Changing Oral Therapeutics

In the July 2021 issue of ONDrugDelivery, Niklas Sandler and Thomas West consider the technological advances in nanoparticle engineering that can improve the bioavailability and delivery of oral therapeutics.

Learn more
PharmSci NANO
November 2, 2021

Poster presentation : ‘’Small is powerful : Comparison of approaches to tackle poor solubility of drugs’’ at AAPS PharmSci 360 2021

Nanoform Director of Pharmaceutical Development, Satu Lakio, presented a poster to AAPS on the effectiveness of Nanoformed particles compared clinically against two commercially approved products.

Learn more
PharmSci NANO
October 22, 2021

Video presentation: Demonstrating the Power of Controlled-Expansion scCO2 Applied to Drug Development at AAPS PharmSci 360 2021

Watch Nanoform Director of Pharmaceutical Development, Satu Lakio, present to AAPS how effective Nanoformed particles could be when compared clinically against two commercially approved products.

Learn more
October 15, 2021

“Nanoformers, Particles in Disguise! – Illuminating the future of Pharma with STARMAP®.” PharmaTech Integrates 2021

Nanoform were attendees at Life Science Integrates’ and the Medicines Manufacturing Innovation Centre’s one-day event, PharmaTech Integrates. Science & Technology Team Leader, Elisabetta Micelotta, hosted the technical showcase “Nanoformers, Particles in Disguise! – Illuminating the future of Pharma with STARMAP®.” In this session, she discussed the power of AI for streamlining drug development.
Learn more
999999999.20211008151441206.999999999.20211008151441206qxaau
October 8, 2021

“Revolution not evolution of Biologics production” PharmaTech Integrates 2021

Nanoform were attendees at Life Science Integrates’ and the Medicines Manufacturing Innovation Centre’s one-day event, PharmaTech Integrates. Our Commercial Insights Officer, Jamie Unwin shared his thoughts on the “Revolution not evolution of Biologics production” panel. The session explored how the industry can step up to meet patient need and market demand by streamlining, enhancing and integrating upstream and downstream biological and vaccine production.

Learn more
nanoform-6
September 23, 2021

Applying AI and our innovative nanoforming technologies to achieve our patient-centric ambitions

David McCelland from Life Science Knowledge Hub interviews Jamie Unwin, our Commercial Insights Officer at Nanoform. They discuss Nanoform’s growth and their ambition of touching the lives of billion patients. Jamie also emphasises the importance of their data-driven approach and how AI is transforming the approach to drug development.

Learn more
nanoform-2
September 13, 2021

“Preparing for Patient-Centric Drug Development Regulations” American DDF Summit 2021

The Nanoform team attended the American DDF Summit (Drug Delivery & Formulation) with Commercial Insights Officer Jamie Unwin chairing a panel discussion titled “Preparing for Patient-Centric Drug Development Regulations”. The session explored the topic of patient centric drug design and how patient centricity can influence the drug development process.

Learn more
June 11, 2021

Nanoform’s transformation a year on from the IPO

A year on from Nanoform’s IPO in June 2020, we have made trailblazing progress. In this video, we share how we’ve transformed to reach key milestones, from the launch of our biologics technology to the completion of our first-in-human trial of a nanoformed drug candidate.

Learn more
June 3, 2021

Video: CPhI Discover 2021 presentation

We were pleased to host a session, “Overcoming Drug Development Challenges with Nanotechnology,” at the first ever CPhI Discover virtual event. Nanoform CCO Christian Jones, FRSC, Nanoform Science & Technology Team Leader Elisabetta Micelotta, and experts from Johnson Matthey and Quotient Sciences shared insights into the power of sparse-data AI in drug development and the collaborative studies investigating the performance of our CESS® technology.

Watch it here to learn more about AI-guided nanoparticle engineering in Pharma, from early drug development to clinic.

Learn more
May 20, 2021

Video: Bio Integrates 2021 panel discussion

Our CCO, Christian Jones, FRSC, joined the Bio Integrates panel discussion “Start with an end in mind” on Thursday, May 20th, 2021. The panel explored the importance of connecting with patients to make sure that  products are designed around the patient’s needs.



Learn more
nanoform-quotient-sciences-image
May 18, 2021

Positive results from first-in-human trial of nanoformed piroxicam

Overcoming Drug Development Challenges with Nanotechnology: Piroxicam, a commercially available non-steroidal anti-inflammatory drug, was nanoformed as a model compound to demonstrate the potential benefits of our CESS(R) nanoforming technology for improving solubility, dissolution and in vivo absorption.

Learn more
nanoform-the-nanomed-zone-image
May 12, 2021

Video: The Nanomed Zone webinar

We were excited to showcase the results from our collaboration with Johnson Matthey in our webinar with The Nanomed Zone: “How CESS® technology stacks up against the competition: the smaller, the better!”.

Watch the presentation to learn how CESS® nanoparticles of a model compound have been found to exhibit improved dissolution performance relative to all other industry standard approaches tested, including spray drying.



Learn more
April 16, 2021

12th Global DDF Summit

Our Director of Pharmaceutical Development, Satu Lakio, gave a presentation at the 12th Global DDF Summit (Drug Delivery & Formulation) covering “Unique Nanoforming Technology for Poorly Soluble APIs by Nanoform”.

Learn more
nanoform-bio-europe-spring-featured
March 30, 2021

Video: Bio-Europe panel discussion

Our Head of AI, Prof. Jukka Corander joined a panel discussion at BIO-Europe Spring 2021 on “Big data & AI: applications in the real world”. Watch the video to find out out how Sparse Data AI & specifically STARMAP® can transform healthcare.

Learn more
January 13, 2021

Video: Nanoform 2020 in review

We achieved a number of milestones in 2020, check out the highlights here!

Learn more

Contact us

+358 29 370 0150
info@nanoform.com

  • Privacy notice
  • Cookies

Subscribe

Read more about our protection of your personal data.

Nanoform Finland Oyj
Cultivator II, Viikinkaari 4
FI-00790 Helsinki
Finland
Company number: 2730572-8